Plasma Fractionation Global Market Analysis, Trends, Growth, Research And Forecast 2033

The plasma fractionation market size has grown strongly in recent years. It will grow from $28.95 billion in 2023 to $31.78 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to growing prevalence of hemophilia and immunodeficiency disorders, increased aging population, rising demand for immunoglobulins, expansion of plasma collection centers, growing number of surgical procedures .

The plasma fractionation market size is expected to see rapid growth in the next few years. It will grow to $46.72 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to rising global healthcare expenditure, growing applications of plasma-derived medicinal products, increasing investment in research and development, demand for plasma in the treatment of neurological disorders, expansion of plasma fractionation facilities. Major trends in the forecast period include development of new fractionation technologies, shift towards albumin and immunoglobulin therapies, rising demand for specialty plasma products, focus on pathogen inactivation technologies, strategic collaborations and partnerships in the plasma industry.

Market Overview -
Plasma fractionation refers to the process of integrating manufacturing procedures to isolate the crude fractions that are then refined into specific medicinal products, in a sequential and integrated manner.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=7543&type=smp

Elevated Demand For Plasma Fractionation Driven By The Escalating Burden Of Chronic Diseases
The increasing number of chronic diseases is expected to propel the growth of the plasma fractionation market going forward. Chronic diseases are defined as conditions that last 1 year or more and require ongoing medical attention, their examples include diseases such as heart disease, cancer, and diabetes. Treatment of patients with chronic diseases through access to plasma products reduces morbidity, improves the quality of life, and is cost-effective, this will in turn increase the demand for plasma fractionation. For instance, in January 2023, according to a report published by the National Library of Medicine, a US-based agency, the number of individuals aged 50 years and older having one or more chronic illnesses is projected to rise by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020 in the United States. Therefore, increasing cases of chronic diseases are driving the growth of the healthcare analytical testing service market. Therefore, an increasing number of chronic diseases of all ages is expected to propel the plasma fractionation market growth.

Competitive Landscape -
Major companies operating in the plasma fractionation market report are Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, ProMetic Life Sciences Inc., Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Shire PLC, Takeda Pharmaceutical Company, Terumo BCT, Bioverativ Inc., China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Grifols International S. A., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP

Revolutionizing Plasma Fractionation Market Through Technological Advancements
Technological advancements are the key trends gaining popularity in the plasma fractionation market. Major companies operating in the market are introducing new technologies, such as HYCON, that work on self-cleaning and fully automatic separators, to sustain their position in the market. For instance, in June 2021, GAE, a Germany-based company that manufactures systems for pharmaceutical sectors, launched HYCON, a fully automatic separator. That enables one-touch production for the separation of blood plasma and plasma proteins in clean room applications. With the help of the self-cleaning and fully automatic separator, it helps to improve hygienic conditions, cross-contamination prevention, and batch safety.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Key Segments -

The plasma fractionation market covered in this report is segmented -

1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors
2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology
3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.